CLINICAL_TRIALS
ClinicalTrials.gov record update
Intranasal Bevacizumab for HHT-Related Epistaxis
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02389959
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:31.307300+00:00
- Published At
- 2021-02-15T00:00:00+00:00
- Record Updated At
- 2021-09-01
- Results Posted At
- 2021-02-15
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["HHT", "Hereditary Hemorrhagic Telangiectasia", "Epistaxis", "Nose Bleeds", "Nasal Bleeding"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-09-01"- protocolSection.identificationModule.nctId
"NCT02389959"- protocolSection.identificationModule.officialTitle
"Intranasal Bevacizumab for HHT-Related Epistaxis"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-02-15"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.